Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAssura Regulatory News (AGR)

Share Price Information for Assura (AGR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 42.60
Bid: 42.48
Ask: 42.56
Change: -0.08 (-0.19%)
Spread: 0.08 (0.188%)
Open: 42.86
High: 42.86
Low: 42.10
Prev. Close: 42.68
AGR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notice of Dividend

29 Feb 2024 07:00

RNS Number : 8595E
Assura PLC
29 February 2024
 

 

29 February 2024

Assura plc

 

Notice of Dividend

 

Assura plc ("Assura" or "the Company"), the UK's leading primary care property investor and developer, today announces that the next quarterly interim dividend of 0.82 pence per share will be paid on 10 April 2024 to shareholders on the register on 8 March 2024 (the "Record Date"). The Ex-dividend Date will be 7 March 2024.

 

This interim dividend will be wholly Property Income Distribution ("PID"). Forms to register for gross PIDs are available on the Company's website and must be returned to the Company registrars, Link Group at 10th Floor, Central Square, 29 Wellington Street, Leeds, LS1 4DL to arrive by 4.30pm on 26 March 2024.Please refer to Company's website HERE for more information.

 

Shareholders may choose for the dividend to be paid either as cash or to be settled in New Shares via the Scrip Dividend Alternative. The Scrip Dividend Alternative price is to be calculated using the average of the middle market quotations for an Ordinary Share, as derived from the Daily Official List of the London Stock Exchange, for the five consecutive business days commencing on the Ex-dividend Date and will be announced by the Company and detailed on the Company's website on 14 March 2024.

 

Any shareholders wishing to take up the Scrip Dividend Alternative, who have not already done so, will have until 4.30pm on 26 March 2024 either to return their completed mandate form to the Company registrars, Link Group at 10th Floor, Central Square, 29 Wellington Street, Leeds, LS1 4DL (in the case of shareholdings in certificated form) or to take the necessary action via the CREST system (in the case of shareholdings in uncertificated form).

 

The Circular concerning this Scrip Dividend Alternative is available on the Company's website, www.assuraplc.com and is also available for inspection at the National Storage Mechanism https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

- Ends -

 

For more information, please contact:

 

Assura plc David Purcell, Investor Relations Director

Tel: 0161 515 2043 Email: Investor@assura.co.uk

 

FGS Global

Gordon Simpson

 

Tel: 0207 251 3801 Email: Assura@fgsglobal.com

 

 

 Notes to Editors

Assura plc is a national healthcare premises specialist and UK REIT based in Altrincham, UK - caring for more than 600 primary healthcare buildings, from which over six million patients are served.

 

A constituent of the FTSE 250 and the EPRA* indices, as at 30 September 2023, Assura's portfolio was valued at £2.7 billion.

 

At Assura, we BUILD for health. Assura builds better spaces for people and places, invests in skills and inspires new ways of working, and unlocks the power of design and innovation to deliver lasting impact for communities - aiming for six million people to have benefitted from improvements to and through its healthcare buildings by 2026. 

 

Assura is leading for a sustainable future, targeting net zero carbon across its portfolio by 2040.

 

Further information is available at www.assuraplc.com

 

*EPRA is a registered trademark of the European Public Real Estate Association.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVPPUAUPUPCGRR
Date   Source Headline
16th Jan 20177:00 amRNSScrip Dividend Declaration
22nd Dec 20167:00 amRNSScrip Calculation Price
8th Dec 20167:00 amRNSNotice of Dividend
22nd Nov 20167:00 amRNSInterim Results 2016
1st Nov 20167:00 amRNSTotal Voting Rights
21st Oct 20162:37 pmRNSNotification of Major Interest in Shares
19th Oct 20169:00 amRNSNotification of Transaction by PDMR
17th Oct 20167:00 amRNSScrip Dividend Declaration
3rd Oct 20167:00 amRNSAppointment of Interim CEO and director
3rd Oct 20167:00 amRNSTrading Update
22nd Sep 20167:00 amRNSScrip Calculation Price
20th Sep 20165:14 pmRNSNotification of Major Interest in Shares
16th Sep 20163:35 pmRNSNotification of Major Interest in Shares
13th Sep 201611:05 amRNSNotification of transactions by PDMRs
8th Sep 20167:00 amRNSNotice of Dividend
1st Sep 20168:00 amRNSTotal Voting Rights
31st Aug 20164:49 pmRNSExercise of Nil Cost Options under VCP
26th Aug 201611:00 amRNSAdditional Listing
9th Aug 20168:00 amRNSDirector/PDMR Shareholdings
1st Aug 20168:00 amRNSTotal Voting Rights
29th Jul 201611:44 amRNSAnnual Information Update
27th Jul 20168:00 amRNSDirector/PDMR Shareholdings
25th Jul 20168:00 amRNSScrip Dividend Declaration
19th Jul 20164:40 pmRNSResult of AGM
19th Jul 20167:00 amRNSTrading Update
4th Jul 201611:34 amRNSGraham Roberts
30th Jun 20167:00 amRNSScrip Calculation Price
17th Jun 20169:11 amRNSPayment on cessation of directorship
16th Jun 20169:00 amRNSNotice of Dividend
15th Jun 20164:16 pmRNSAnnual Report & Notice of AGM
14th Jun 20167:00 amRNSUpdate statement regarding Graham Roberts
23rd May 20163:48 pmRNSDirector/PDMR Shareholding
18th May 20167:00 amRNSFull Year Results
6th May 20169:34 amRNSNotification of Major Interest in Shares
4th May 20169:01 amRNSTotal Voting Rights
26th Apr 201612:24 pmRNSNotification of Major Interest in Shares
20th Apr 201612:28 pmRNSNotification of Major Interest in Shares
20th Apr 20167:00 amRNSDirector/PDMR Shareholdings
18th Apr 20167:00 amRNSScrip Dividend Declaration
24th Mar 20164:25 pmRNSNotification of Major Interest in Shares
24th Mar 201612:22 pmRNSScrip calculation price
22nd Mar 20166:05 pmRNSDirector/PDMR Shareholding
22nd Mar 20163:56 pmRNSNotification of Major Interest in Shares
21st Mar 20167:00 amRNSDirector/PDMR Shareholding
15th Mar 201611:54 amRNSDirector/PDMR Shareholding
10th Mar 20167:00 amRNSNotice of Dividend
4th Mar 20167:00 amRNSFurther statement regarding Graham Roberts
29th Feb 20167:00 amRNSDirector Declaration
9th Feb 20167:05 amRNSTrading Update
9th Feb 20167:00 amRNSStatement regarding Chief Executive Graham Roberts

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.